Kos Biotechnology Partners
VC · Athens · United States
Etapas
Región de inversión
Industrias
Perfil
Kos Biotechnology Partners is a life sciences investment firm with headquarters in New York City and Athens, Greece. It was founded by Dr. Simos Simeonidis, who has extensive experience in biomedical research and financial analysis, and Alex Tzoukas, an expert in healthcare investment banking and private equity. The firm is managed alongside Nikos Kostaras, who brings operational expertise from his time at IQVIA. The team is known for building a bridge between the US and European biopharma ecosystems and leverages a network of advisors from the Greek diaspora to scale their portfolio companies globally. Kos focuses on high-impact investments within the life sciences sector, specifically targeting biotech/novel therapeutics, pharma services, and tech-enabled sectors that integrate AI and modern defense applications. With a flexible approach to deploying capital across all stages of company development, they invest from company formation through Series C. The Global Life Sciences Fund currently has $123M in commitments, backed by institutions like the Hellenic Development Bank of Investments and other global family offices. Notable investments by Kos include leading a financing round for Epikast, a tech-enabled pharma services provider, and investing strategically in a biotechnology company based in San Francisco. Their portfolio is poised to grow with additional investments planned for completion within the year.
Contactos (2)
| Nombre | Cargo | Teléfono | ||
|---|---|---|---|---|
| Managing Partner | — | — | — | |
| Managing Partner | — | — | — |
El nombre, email y teléfono se muestran en sombra. Suscribite para verlos completos.